REPORT ID 9101

United States Respiratory Inhaler Devices Market Report 2017

Publish Date
10-Nov-17
Pages
104
Format
Electronic (PDF)

In this report, the United States Respiratory Inhaler Devices market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Respiratory Inhaler Devices in these regions, from 2012 to 2022 (forecast).

United States Respiratory Inhaler Devices market competition by top manufacturers/players, with Respiratory Inhaler Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    AstraZeneca
    Beximco Pharmaceuticals Ltd.
    Boehringer Ingelheim GmbH
    Cipla Ltd.
    GlaxoSmithKline plc
    Koninklijke Philips N.V.
    Merck & Co., Inc.
    OMRON Healthcare Europe B.V.
    PARI Medical Holding
    Teva Pharmaceutical Industries Ltd

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Dry Powder Inhaler
    Metered Dose Inhaler
    Nebulizer
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Asthma
    COPD
    Pulmonary Arterial Hypertension
    Other Respiratory Disease

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Respiratory Inhaler Devices Market Report 2017
1 Respiratory Inhaler Devices Overview
    1.1 Product Overview and Scope of Respiratory Inhaler Devices
    1.2 Classification of Respiratory Inhaler Devices by Product Category
        1.2.1 United States Respiratory Inhaler Devices Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Respiratory Inhaler Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Dry Powder Inhaler
        1.2.4 Metered Dose Inhaler
        1.2.5 Nebulizer
    1.3 United States Respiratory Inhaler Devices Market by Application/End Users
        1.3.1 United States Respiratory Inhaler Devices Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Asthma
        1.3.3 COPD
        1.3.4 Pulmonary Arterial Hypertension
        1.3.5 Other Respiratory Disease
    1.4 United States Respiratory Inhaler Devices Market by Region
        1.4.1 United States Respiratory Inhaler Devices Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Respiratory Inhaler Devices Status and Prospect (2012-2022)
        1.4.3 Southwest Respiratory Inhaler Devices Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Respiratory Inhaler Devices Status and Prospect (2012-2022)
        1.4.5 New England Respiratory Inhaler Devices Status and Prospect (2012-2022)
        1.4.6 The South Respiratory Inhaler Devices Status and Prospect (2012-2022)
        1.4.7 The Midwest Respiratory Inhaler Devices Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Respiratory Inhaler Devices (2012-2022)
        1.5.1 United States Respiratory Inhaler Devices Sales and Growth Rate (2012-2022)
        1.5.2 United States Respiratory Inhaler Devices Revenue and Growth Rate (2012-2022)

2 United States Respiratory Inhaler Devices Market Competition by Players/Suppliers
    2.1 United States Respiratory Inhaler Devices Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Respiratory Inhaler Devices Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Respiratory Inhaler Devices Average Price by Players/Suppliers (2012-2017)
    2.4 United States Respiratory Inhaler Devices Market Competitive Situation and Trends
        2.4.1 United States Respiratory Inhaler Devices Market Concentration Rate
        2.4.2 United States Respiratory Inhaler Devices Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Respiratory Inhaler Devices Manufacturing Base Distribution, Sales Area, Product Type

3 United States Respiratory Inhaler Devices Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Respiratory Inhaler Devices Sales and Market Share by Region (2012-2017)
    3.2 United States Respiratory Inhaler Devices Revenue and Market Share by Region (2012-2017)
    3.3 United States Respiratory Inhaler Devices Price by Region (2012-2017)

4 United States Respiratory Inhaler Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Respiratory Inhaler Devices Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Respiratory Inhaler Devices Revenue and Market Share by Type (2012-2017)
    4.3 United States Respiratory Inhaler Devices Price by Type (2012-2017)
    4.4 United States Respiratory Inhaler Devices Sales Growth Rate by Type (2012-2017)

5 United States Respiratory Inhaler Devices Sales (Volume) by Application (2012-2017)
    5.1 United States Respiratory Inhaler Devices Sales and Market Share by Application (2012-2017)
    5.2 United States Respiratory Inhaler Devices Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Respiratory Inhaler Devices Players/Suppliers Profiles and Sales Data
    6.1 AstraZeneca
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 AstraZeneca Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Beximco Pharmaceuticals Ltd.
        6.2.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Beximco Pharmaceuticals Ltd. Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Boehringer Ingelheim GmbH
        6.3.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Boehringer Ingelheim GmbH Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Cipla Ltd.
        6.4.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Cipla Ltd. Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 GlaxoSmithKline plc
        6.5.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 GlaxoSmithKline plc Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Koninklijke Philips N.V.
        6.6.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Koninklijke Philips N.V. Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Merck & Co., Inc.
        6.7.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Merck & Co., Inc. Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 OMRON Healthcare Europe B.V.
        6.8.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 OMRON Healthcare Europe B.V. Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 PARI Medical Holding
        6.9.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 PARI Medical Holding Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Teva Pharmaceutical Industries Ltd
        6.10.2 Respiratory Inhaler Devices Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Teva Pharmaceutical Industries Ltd Respiratory Inhaler Devices Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview

7 Respiratory Inhaler Devices Manufacturing Cost Analysis
    7.1 Respiratory Inhaler Devices Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Respiratory Inhaler Devices

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Respiratory Inhaler Devices Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Respiratory Inhaler Devices Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Respiratory Inhaler Devices Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Respiratory Inhaler Devices Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Respiratory Inhaler Devices Sales Volume Forecast by Type (2017-2022)
    11.3 United States Respiratory Inhaler Devices Sales Volume Forecast by Application (2017-2022)
    11.4 United States Respiratory Inhaler Devices Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer